Effectiveness of the BNT162b2 vaccine among children 5-11 and 12-17 years in New York after the Emergence of the Omicron Variant

Vajeera Dorabawila, Dina Hoefer, Ursula E. Bauer, Mary T. Bassett, Emily Lutterloh, Eli S. Rosenberg
doi: https://doi.org/10.1101/2022.02.25.22271454

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Back to top
Posted February 28, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Effectiveness of the BNT162b2 vaccine among children 5-11 and 12-17 years in New York after the Emergence of the Omicron Variant
Vajeera Dorabawila, Dina Hoefer, Ursula E. Bauer, Mary T. Bassett, Emily Lutterloh, Eli S. Rosenberg
medRxiv 2022.02.25.22271454; doi: https://doi.org/10.1101/2022.02.25.22271454
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area